The NexWaves unique 3-modalities-in-1-device for Home TENS, Interferential, & NMES is designed to break the pain cycle.

April 1, 2016 - Clinical study, "A Preliminary Evaluation of a Novel System for Monitoring Blood Loss in Clinical Settings" published. Click here to download the study.

Sept. 23, 2015 (GLOBE NEWSWIRE) Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac and neurological diagnostics, and compound pharmacy, announced today that its wholly-owned subsidiary, Zynex Monitoring Solutions Inc., has filed an application with the Food and Drug Administration pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM1500 monitoring device. The CM1500 is capable of monitoring a patient's fluid levels, including blood loss, during surgery and in recovery.

More Information